From nikko at hailmail.net  Sun Jan 11 20:26:13 2009
From: nikko at hailmail.net (Nicholas Lewin-Koh)
Date: Sun, 11 Jan 2009 11:26:13 -0800
Subject: [Rd] NY Times article
In-Reply-To: <496A0E73.2020805@vanderbilt.edu>
References: <496A0E73.2020805@vanderbilt.edu>
Message-ID: <1231701973.25565.1294170219@webmail.messagingengine.com>

Hi Frank,
Thank you for the correction, I don't work in clinical, so good you keep
me honest.
Nicholas
On Sun, 11 Jan 2009 09:21:23 -0600, "Frank E Harrell Jr"
<f.harrell at vanderbilt.edu> said:
> Nicholas please note that FDA does not require type III sums of squares, 
> LOCF, and the use of any particular software.  It is just the fact that 
> FDA does not disallow type III tests and LOCF that prevents pharma from 
> abandoning these terrible methods.
> 
> Frank
> -- 
> Frank E Harrell Jr   Professor and Chair           School of Medicine
>                       Department of Biostatistics   Vanderbilt University



[Rd] NY Times article
Nicholas Lewin-Koh